Cofactor Genomics
Matching cancer patients to treatment using the power of RNA
Cofactor Genomics is a biotech company focused on predictive diagnostics for oncology, using RNA sequencing to match cancer patients to appropriate immunotherapy treatments. Their platform employs multidimensional biomarkers rather than single-analyte approaches to better predict patient response before treatment decisions are made. They offer sponsored research and clinical study programs for oncologists, pathologists, and clinical researchers.
The platform uses RNA sequencing and multidimensional biomarker models to generate predictive diagnostics about tumor response to immunotherapy.
Medical oncologists, pathologists, and clinical researchers in immuno-oncology
Background.
- Status
- launched
- Business model
- unknown
- Company
- Cofactor Genomics
Similar projects.
Editorial take on the space this project sits in — momentum signals, adjacent moves, our call on whether the wedge is real. Get pinged when we publish a new read or when the landscape shifts.
Have a take on this space?
Tell us what you’d build differently, where you think the incumbents miss, or what we’ve gotten wrong about this project. Comments + reactions are coming soon.